Bristol-Myers Squibb Company v. Sigmapharm Laboratories, LLC

COMPLAINT for PATENT INFRINGEMENT filed against Sigmapharm Laboratories, LLC - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2119525.) - filed by Bristol-Myers Squibb Company, Pfizer Inc. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Civil Cover Sheet)(ceg) (Entered: 04/11/2017)

2017-04-10

1

Download

COMPLAINT for PATENT INFRINGEMENT filed against Sigmapharm Laboratories, LLC - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2119525.) - filed by Bristol-Myers Squibb Company, Pfizer Inc. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Civil Cover Sheet)(ceg) (Entered: 04/11/2017)

2017-04-10

2

View

COMPLAINT for PATENT INFRINGEMENT filed against Sigmapharm Laboratories, LLC - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2119525.) - filed by Bristol-Myers Squibb Company, Pfizer Inc. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Civil Cover Sheet)(ceg) (Entered: 04/11/2017)

2017-04-10

2

View

COMPLAINT for PATENT INFRINGEMENT filed against Sigmapharm Laboratories, LLC - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2119525.) - filed by Bristol-Myers Squibb Company, Pfizer Inc. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Civil Cover Sheet)(ceg) (Entered: 04/11/2017)

2017-04-10

2

View

COMPLAINT for PATENT INFRINGEMENT filed against Sigmapharm Laboratories, LLC - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2119525.) - filed by Bristol-Myers Squibb Company, Pfizer Inc. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Civil Cover Sheet)(ceg) (Entered: 04/11/2017)

2017-04-10

2

View

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (ceg) (Entered: 04/11/2017)

2017-04-10

1

View

Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 3/8/2017. Date of Expiration of Patent: See Attached.Thirty Month Stay Deadline: 6/28/2020. (ceg) (Entered: 04/11/2017)

2017-04-10

1

View

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 6,967,208 B2; US 9,326,945 B2. (ceg) (Entered: 04/11/2017)

2017-04-10

1

View

Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Bristol-Myers Squibb Company. (ceg) (Entered: 04/11/2017)

2017-04-10

1

View

Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Pfizer Inc. (ceg) (Entered: 04/11/2017)

2017-04-10

1

View

Summons Issued with Magistrate Consent Notice attached as to Sigmapharm Laboratories, LLC on 4/11/2017. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (ceg)

2017-04-11

1

No Actions

Summons Issued

2017-04-11

1

No Actions

Case Assigned to Judge Leonard P. Stark. Please include the initials of the Judge (LPS) after the case number on all documents filed. Associated Cases: 1:17-cv-00374-LPS through 1:17-cv-00382-LPS and 1:17-cv-00398-LPS through 1:17-cv-00412-LPS (rjb)

2017-04-12

1

No Actions

Case Assigned/Reassigned

2017-04-12

1

No Actions

SUMMONS Returned Executed by Bristol-Myers Squibb Company, Pfizer Inc.. Sigmapharm Laboratories, LLC served on 4/17/2017, answer due 5/8/2017. (Farnan, Michael) (Entered: 04/18/2017)

2017-04-18

1

View

MOTION for Pro Hac Vice Appearance of Attorney Amy K. Wigmore, Gregory H. Lantier, Tracey C. Allen, Heather M. Petruzzi, Andrew J. Danford, Jeffrey T. Hantson, Timothy A. Cook, and Kevin M. Yurkerwich - filed by Bristol-Myers Squibb Company, Pfizer Inc.. (Farnan, Brian) (Entered: 05/04/2017)

2017-05-04

1

View

STIPULATION TO EXTEND TIME to Respond to Complaint to June 12, 2017 - filed by Bristol-Myers Squibb Company, Pfizer Inc.. (Farnan, Michael) (Entered: 05/05/2017)

2017-05-05

1

View

SO ORDERED, re (8 in 1:17-cv-00408-LPS, 9 in 1:17-cv-00374-LPS, 7 in 1:17-cv-00378-LPS, 8 in 1:17-cv-00412-LPS, 9 in 1:17-cv-00409-LPS, 9 in 1:17-cv-00404-LPS, 8 in 1:17-cv-00382-LPS, 9 in 1:17-cv-00403-LPS, 8 in 1:17-cv-00376-LPS, 8 in 1:17-cv-00381-LPS, 8 in 1:17-cv-00407-LPS, 10 in 1:17-cv-00411-LPS, 8 in 1:17-cv-00380-LPS, 7 in 1:17-cv-00405-LPS, 10 in 1:17-cv-00410-LPS, 8 in 1:17-cv-00398-LPS, 7 in 1:17-cv-00399-LPS, 8 in 1:17-cv-00400-LPS, 8 in 1:17-cv-00426-LPS, 7 in 1:17-cv-00375-LPS, 8 in 1:17-cv-00406-LPS, 10 in 1:17-cv-00377-LPS, 9 in 1:17-cv-00379-LPS, 9 in 1:17-cv-00401-LPS, 8 in 1:17-cv-00402-LPS) MOTION for Pro Hac Vice Appearance of Attorney Amy K. Wigmore, Gregory H. Lantier, Tracey C. Allen, Heather M. Petruzzi, Andrew J. Danford, Jeffrey T. Hantson, Timothy A. Cook, and Kevin M. Yurkerwich filed by Pfizer Inc., Bristol-Myers Squibb Company. Signed by Judge Leonard P. Stark on 5/5/17. Associated Cases: 1:17-cv-00374-LPS et al. (ntl)

2017-05-05

1

No Actions

SO ORDERED

2017-05-05

1

No Actions

SO ORDERED, re 9 STIPULATION TO EXTEND TIME to Respond to Complaint to June 12, 2017 filed by Pfizer Inc., Bristol-Myers Squibb Company. Signed by Judge Leonard P. Stark on 5/9/17. (ntl)

2017-05-09

1

No Actions

SO ORDERED

2017-05-09

1

No Actions

Add Attorneys - PHV only

2017-05-10

1

No Actions

Add Attorneys - PHV only

2017-05-10

1

No Actions

Pro Hac Vice Attorney Tracey C. Allen for Bristol-Myers Squibb Company added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:17-cv-00375-LPS et al.(dmp, )

2017-05-10

1

No Actions

Pro Hac Vice Attorney Amy K. Wigmore for Bristol-Myers Squibb Company added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:17-cv-00375-LPS et al.(crb)

2017-05-10

1

No Actions

Add Attorneys - PHV only

2017-05-11

1

No Actions

Add Attorneys - PHV only

2017-05-11

1

No Actions

Pro Hac Vice Attorney Timothy Cook for Bristol-Myers Squibb Company added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:17-cv-00406-LPS, 1:17-cv-00407-LPS, 1:17-cv-00408-LPS, 1:17-cv-00409-LPS(crb)

2017-05-11

1

No Actions

Pro Hac Vice Attorney Kevin M. Yurkerwich for Bristol-Myers Squibb Company added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:17-cv-00377-LPS et al.(crb)

2017-05-11

1

No Actions

Pro Hac Vice Attorney Jeffrey T. Hantson for Bristol-Myers Squibb Company added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:17-cv-00374-LPS et al.(crb)

2017-05-11

1

No Actions

Pro Hac Vice Attorney Heather M. Petruzzi for Bristol-Myers Squibb Company added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:17-cv-00375-LPS et al.(crb)

2017-05-11

1

No Actions

Add Attorneys - PHV only

2017-05-19

1

No Actions

Pro Hac Vice Attorney Andrew J. Danford for Bristol-Myers Squibb Company added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:17-cv-00412-LPS et al.(crb)

2017-05-19

1

No Actions

ANSWER to 1 Complaint, Affirmative Defenses, COUNTERCLAIM against All Plaintiffs by Sigmapharm Laboratories, LLC.(Phillips, John) (Entered: 06/12/2017)

2017-06-12

1

View

Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Sigmapharm Laboratories, LLC. (Phillips, John) (Entered: 06/12/2017)

2017-06-12

1

View

MOTION for Pro Hac Vice Appearance of Attorney Marc R. Wezowski, Don J. Mizerk, Philip D. Segrest, Jr. and Dustin L. Taylor - filed by Sigmapharm Laboratories, LLC. (Attachments: # 1 Certification of Marc R. Wezowski, # 2 Certification of Don J. Mizerk, # 3 Certification of Philip D. Segrest, Jr., # 4 Certification of Dustin L. Taylor)(Bilson, David) (Entered: 06/12/2017)

2017-06-12

1

View

SO ORDERED

2017-06-14

1

No Actions

SO ORDERED, re 12 MOTION for Pro Hac Vice Appearance of Attorney Marc R. Wezowski, Don J. Mizerk, Philip D. Segrest, Jr. and Dustin L. Taylor filed by Sigmapharm Laboratories, LLC. Signed by Judge Leonard P. Stark on 6/14/17. (ntl)

2017-06-14

1

No Actions

Add Attorneys - PHV only

2017-06-16

1

No Actions

Pro Hac Vice Attorney Marc R. Wezowski for Sigmapharm Laboratories, LLC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (nmg)

2017-06-16

1

No Actions

ANSWER to 10 Answer to Complaint, Counterclaim by Bristol-Myers Squibb Company, Pfizer Inc..(Farnan, Michael) (Entered: 06/30/2017)

2017-06-30

1

View

Add Attorneys - PHV only

2017-06-30

1

No Actions

Pro Hac Vice Attorney Philip D. Segrest, Dustin L. Taylor and Don J. Mizerk for Sigmapharm Laboratories, LLC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (nmg)

2017-06-30

1

No Actions

ORAL ORDER: IT IS HEREBY ORDERED that the parties shall confer regarding proposed dates in the scheduling order and shall submit a proposal, including a proposal for the length and timing of trial, to the Court no later than September 22, 2017. The parties are to review the Court's form scheduling order, which is posted at http://www.ded.uscourts.gov (see Chambers, Judge Stark, New Patent Procedures). ORDERED by Judge Leonard P. Stark on 8/31/17. Associated Cases: 1:17-cv-00374-LPS et al. (ntl) (Entered: 08/31/2017)

2017-08-31

1

View

Order

2017-08-31

1

No Actions

PROPOSED ORDER Proposed Scheduling Order by Bristol-Myers Squibb Company, Pfizer Inc.. (Attachments: # 1 Letter to The Honorable Leonard P. Stark)(Farnan, Michael) (Entered: 09/22/2017)

2017-09-22

1

View

NOTICE OF SERVICE of Defendant Sigmapharm Laboratories, LLC's Rule 26(A)(1) Initial Disclosures filed by Sigmapharm Laboratories, LLC.(Bilson, David) (Entered: 10/27/2017)

2017-10-27

1

View

NOTICE OF SERVICE of Plaintiffs' Fed. R. Civ. P. 26(a)(1) Initial Disclosures filed by Bristol-Myers Squibb Company, Pfizer Inc..(Farnan, Michael) (Entered: 10/27/2017)

2017-10-27

1

View

NOTICE OF SERVICE of (i) Plaintiffs' First Set of Common Requests for Production of Documents and Things and (ii) Plaintiffs' First Set of Common Interrogatories filed by Bristol-Myers Squibb Company, Pfizer Inc..(Farnan, Michael) (Entered: 10/30/2017)

2017-10-30

1

View

SCHEDULING ORDER: Case referred to the Magistrate Judge for the purpose of exploring ADR. These actions are CONSOLIDATED for purposes of discovery and all papers shall be filed in Civil Action No. 17-374-LPS. Discovery due by 7/12/2019. Status Report due by 11/30/2018. Claim Construction Opening Brief due by 6/22/2018. Claim Construction Answering Brief due by 7/27/2018. A Markman Hearing is set for 9/4/2018 at 09:00 AM in Courtroom 6B before Judge Leonard P. Stark. Proposed Pretrial Order due by 9/20/2019. A Final Pretrial Conference is set for 9/27/2019 at 09:00 AM in Courtroom 6B before Judge Leonard P. Stark. A Bench Trial (at least 5 days) is set for 10/15/2019 at 08:30 AM in Courtroom 6B before Judge Leonard P. Stark. Signed by Judge Leonard P. Stark on 11/2/17. Associated Cases: 1:17-cv-00374-LPS et al. (ntl) (Entered: 11/02/2017)

2017-11-02

1

View

Oral Order

2017-11-03

1

No Actions

Case Referred to Mediation - Magistrate Judge only

2017-11-03

1

No Actions

CASE REFERRED to Magistrate Judge Burke for Mediation. Please see Standing Order dated January 20, 2016, regarding disclosure of confidential ADR communications. A link to the standing order is provided here for your convenience at http://www.ded.uscourts.gov/general-orders/magistrate-judges-standing-order-adr-mediation Associated Cases: 1:17-cv-00374-LPS et al.(dlb)

2017-11-03

1

No Actions

ORAL ORDER: In light of the District Court's ADR referral in this case, and the number of parties involved in this matter and related cases, the Court orders as follows: Plaintiff(s) counsel shall contact counsel for each defendant to discuss whether both sides believe that the Court's assistance with settlement discussions would be helpful at some point in the case. If both plaintiff(s) and an individual defendant believe that the case has reached a stage whereby the Court's assistance is needed with regard to settlement, plaintiff(s) counsel shall contact the Court to schedule an ADR Teleconference for plaintiff and that individual defendant. Ordered by Judge Christopher J. Burke on 11/3/2017. Associated Cases: 1:17-cv-00374-LPS et al.(dlb)

2017-11-03

1

No Actions

Create Case Association - dkt in member case for Consol or MDL

2017-11-14

1

No Actions

Case associated with lead case: Create association to 1:17-cv-00374-LPS. (ntl)

2017-11-14

1

No Actions

NOTICE requesting Clerk to remove Tracey C. Allen as co-counsel.. (Farnan, Brian) (Entered: 07/30/2019)

2019-07-30

1

View

Terminate Case - Civil

2020-08-13

1

No Actions

CASE CLOSED (See Final Judgment in lead case no. 17-374-LPS at D.I. 739) Associated Cases: 1:17-cv-00380-LPS, 1:17-cv-00382-LPS, 1:17-cv-00408-LPS, 1:19-cv-00055-LPS (ntl)

2020-08-13

1

No Actions

NOTICE of of Appeal by Sigmapharm Laboratories, LLC (Phillips, John) (Entered: 08/28/2020)

2020-08-28

1

View

JUDGMENT of USCA. Decision of USCA: AFFIRMED. (Attachment: # 1 Opinion)(ntl) (Entered: 09/03/2021)

2021-09-03

1

View

MANDATE of USCA (See 9/3/21 Judgment). (ntl) (Entered: 10/13/2021)

2021-10-12

1

View

Overview

Parties

Defendant

Sigmapharm Laboratories, LLC

Represented By

Plaintiff